Klein KR, Boeder SC, Freeman JLR, Dunn I, et al. Impact of the hepatoselective glucokinase activator TTP399 on ketoacidosis during insulin withdrawal in people with type 1 diabetes. Diabetes Obes Metab 2022 Jun 4. doi: 10.1111/dom.14697.
PMID: 35661378